Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In Roka Bioscience, Inc. (ROKA) To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Roka Bioscience, Inc. (“Roka” or the “Company”) (NASDAQ: ROKA) of the February 23, 2015 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Roka and certain officers of the Company.
A complaint has been filed in the United States District Court for the District of New Jersey on behalf of all persons who purchased or otherwise acquired Roka securities between July 17, 2014 and November 6, 2014 (the “Class Period”).
The complaint alleges that the Company and its executives violated federal securities laws with respect to its statements concerning its business, operations, and prospects.
Specifically, the action alleges that during the Class Period, Roka misrepresented and/or failed to disclose the trend of declining demand for its Atlas System and poor sales in the offering documents of its July 17, 2014 initial public offering.
On November 6, 2014, Roka announced its third quarter results, which included a net loss of $0.64 per share. The Company also noted that there were no additional placements of its Atlas instruments in the third quarter.
Following this news, the price of Roka stock declined by $5.34 per share, or over 64%, to close on November 7, 2014 at $3.00 per share.
If you invested in Roka common stock or options between July 17, 2014 and November 6, 2014 and would like to discuss your legal rights, you can contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding Roka’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.